IFNG and neoplasm: Interestingly, the broad elimination of tumor macrophages with an anti-F4/80 CAR led to delayed tumor growth and resulted in CAR-derived-IFNg expression, which resulted in immune editing of the tumor in lung, ovarian, and pancreatic cancer models.